
Print Issues
From the Editors: Racist Logic
By examining the opioid crisis alongside the War on Drugs Murch brings an otherwise familiar story into new territory.
April 8, 2019
Apr 8, 2019
1 Min read time
Share:
By examining the opioid crisis alongside the War on Drugs Murch brings an otherwise familiar story into new territory.
This note appears in Boston Review’s Spring 2019 print issue Racist Logic.
With white mortality rates soaring as a result of opioid use, drug addiction has morphed from a criminal crisis into a health crisis. This should not surprise us since, as Donna Murch notes in her lead essay, “Historically, the fundamental division between ‘dope’ and medicine was the race and class of users.”
But by examining the opioid crisis alongside the War on Drugs— which has locked up so many people of color—as well as the Trump administration’s immigration policies, Murch brings an otherwise familiar story into new territory. To understand the twisted logic that created the divergent responses to drug use—succor and sympathy for white users, prison and expulsion for people of color—Murch draws on Cedric Robinson’s idea of racial capitalism. She shows how a racialized regime of drug prohibitions and a commercialized approach to prescription pharmaceuticals led Purdue Pharma to market OxyContin specifically to whites because it guaranteed them the longest head start on enforcement attempts and thus the biggest profits.
Racist Logic continues Boston Review’s interest in racial capitalism, and readers will find that it resonates with Forum 1, Race Capitalism Justice, to which Murch was also a contributor. Other contributors to Racist Logic consider how the idea of a specifically racial capitalism helps us understand the history of international banking (Peter James Hudson), the consumerism and commodification of black masculinity (Jordanna Matlon), the buying and selling of women’s eggs and uteruses (Alys Eve Weinbaum), Michelle Obama’s dubious bootstrap advice to black youth (Keeanga-Yamahtta Taylor), and the workings of affirmative action at elite universities (Richard Thomspon Ford).
The logic is grim, but there is cause for hope. As we go to press, a number of museums have announced that they will refuse money from the Sackler family, which owns Purdue Pharma—yielding, in part, to protests organized by forum respondent L.A. Kauffman. Moreover, the company settled a $270 million lawsuit with the state of Oklahoma, opening the door for future cases. Our ambitious hope is that Racist Logic will in some way contribute to this momentum.
While we have you...
...we need your help. Confronting the many challenges of COVID-19—from the medical to the economic, the social to the political—demands all the moral and deliberative clarity we can muster. In Thinking in a Pandemic, we’ve organized the latest arguments from doctors and epidemiologists, philosophers and economists, legal scholars and historians, activists and citizens, as they think not just through this moment but beyond it. While much remains uncertain, Boston Review’s responsibility to public reason is sure. That’s why you’ll never see a paywall or ads. It also means that we rely on you, our readers, for support. If you like what you read here, pledge your contribution to keep it free for everyone by making a tax-deductible donation.
April 08, 2019
1 Min read time